To evaluate if the Human epidermal growth factor receptor 2 (HER-2) expression levels may be used as potential prognostic marker in high grade T1 blad- der cancer (T1G3) METHODS: Specimens from transurethral resection of bladder tumour (TURBT) of 103 patients with high-grade T1 bladder cancer were collected. This pathologic database was reviewed. Four-year follow-up data were matched with pathologic data. Eighty-three patients entered the study. HER-2 staining was performed. Patients were grouped for HER-2 status. Statistical analysis included Kaplan Meier survival analysis and Log-rank test.
Bongiovanni, L., Arena, V., Vecchio, F. M., Racioppi, M., Bassi, P., Pierconti, F., HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3), <<ARCHIVIO ITALIANO DI UROLOGIA ANDROLOGIA>>, 2013; 85 (2): 73-77. [doi:10.4081/aiua.2013.2.73] [http://hdl.handle.net/10807/62768]
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3)
Bongiovanni, Luca;Arena, Vincenzo;Vecchio, Fabio Maria;Racioppi, Marco;Bassi, Pierfrancesco;Pierconti, Francesco
2013
Abstract
To evaluate if the Human epidermal growth factor receptor 2 (HER-2) expression levels may be used as potential prognostic marker in high grade T1 blad- der cancer (T1G3) METHODS: Specimens from transurethral resection of bladder tumour (TURBT) of 103 patients with high-grade T1 bladder cancer were collected. This pathologic database was reviewed. Four-year follow-up data were matched with pathologic data. Eighty-three patients entered the study. HER-2 staining was performed. Patients were grouped for HER-2 status. Statistical analysis included Kaplan Meier survival analysis and Log-rank test.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
